Thursday, April 21, 2022 10:14:54 PM
French firm bioMérieux (2021 revenue US$3.82B) is an in vitro diagnostics biotechnology firm whose history traces back to Louis Pasteur. April 12, 2022: bioMérieux announces agreement to acquire Specific Diagnostics (SD), private U.S. based firm, developer of rapid antimicrobial susceptibility test (AST) system delivering phenotypic AST directly from positive blood cultures.(Note: SD system CE marked; not US-FDA approved; RUO) bioMérieux CEO says their 'acquisition reinforces commitment to sustain antibiotic efficacy for future generations.'
The CEO Richard Sayno of Sandoz, world's leading provider of generic antibiotics, said much the same thing about Sandoz's "key" collaboration with OpGen --except he knows, as is evident by his remarks, that OpGen biotech scores more points than Specific Diagnostics' AST given OpGen's far more robust system, FDA Approved, and AI-powered bioinformatics solutions for antibiotic response prediction, to boot.
Sandoz CEO Richard Saynor stated, “Antibiotics are the cornerstone of modern medicine. AMR, which is now estimated to directly account for nearly 1.3 million deaths worldwide every year, is an unprecedented threat to global public health. As the world’s leading provider of generic antibiotics, our goal at Sandoz is to play a key role in overcoming this growing threat. This collaboration (w/OpGen sub) is a key step towards that goal, allowing us to take the fight directly to AMR by using cutting-edge big data and AI approaches combined with traditional data sets. By combining our respective skillsets, we believe we can not only use diagnostic and surveillance data to help healthcare professionals make better diagnoses, but also expand our options to treat AMR in the future, by targeted repurposing of key antibiotics. Our ultimate goal is both simple and radical: to ensure we get the right medicine to the right patient at the right time.”
https://www.globenewswire.com/news-release/2022/04/06/2417469/35690/en/OpGen-s-subsidiary-Ares-Genetics-provides-update-on-collaboration-agreement-to-drive-cutting-edge-digital-solutions-in-global-fight-against-antimicrobial-resistance-AMR.html
Recent OPGN News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2024 04:59:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/22/2024 09:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 09:23:14 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/19/2024 08:56:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 08:15:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 08:39:45 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 08:05:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 09:28:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 09:25:45 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/01/2024 09:25:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/08/2024 08:30:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:01:21 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/30/2024 08:30:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:30:33 PM
- OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q • GlobeNewswire Inc. • 05/24/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:15:20 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/17/2024 09:02:10 PM
- OpGen Announced 1-for-10 Reverse Stock Split • GlobeNewswire Inc. • 05/16/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:30:23 PM
- OpGen Provides Update on Business Operations and Strategic Opportunities • GlobeNewswire Inc. • 04/29/2024 08:05:00 PM
- OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K • GlobeNewswire Inc. • 04/23/2024 08:15:00 PM
- Shares Rip In Reaction To Activist Investor Becoming CEO • AllPennyStocks.com • 03/26/2024 08:20:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM